MME and renal cell carcinoma: Histopathological and immunohistochemical analysis confirmed PRNRP in the right kidney (CK7+, GATA3+, Ki-67 approximately 2%) and RCC-FMS in the left kidney (PAX-8+, CA IX+, CD10+, Ki-67 approximately 3%).